MedWatch

Bavarian Nordic upgrades guidance for third time in three weeks

For the third time in three weeks, Bavarian Nordic has increased its stated financial expectations for the year. This comes after a deal was secured with the US government concerning the firm’s monkeypox vaccine.

Photo: LUKAS BARTH/REUTERS / X03379

Bavarian Nordic has entered into an agreement with the US government concerning the firm’s monkeypox vaccine, and in connection with this, has upgraded its financial guidance again.

It is the third time in under three weeks that Bavarian Nordic has increased its expected revenue.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs